연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
3745. Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers
Do Young Hyeon # 1, Dowoon Nam # 2, Hye-Jin Shin # 3, Juhee Jeong # 4, Eunsoo Jung # 1, Soo Young Cho 3, Dong Hoon Shin 3, Ja-Lok Ku 5, Hye Jung Baek 3, Chong Woo Yoo 3, Eun-Kyung Hong 3, Myong Cheol Lim 3, Sang-Jin Lee 3, Young-Ki Bae 3, Jong Kwang Kim 3, Jingi Bae 2, Wonyoung Choi 3, Su-Jin Kim 2, Seunghoon Back 2, Chaewon Kang 2, Inamul Hasan Madar 2, Hokeun Kim 2, Suhwan Kim 2, Duk Ki Kim 4, Jihyung Kang 4, Geon Woo Park 4, Ki Seok Park 4, Yourae Shin 1, Sang Soo Kim 6, Keehoon Jung 7 8, Dae
Mol Cancer. 2025 Mar 14;24(1):77.
Link
3744. Comparative Assessment of Various Formats of TRAIL in Three-Dimensional Cell Culture and Patient-Derived Tumoroids of Colorectal Cancer
Farzaneh Vafaeinik 1, Sarah Helmueller 1, Alexandra Gangi 2, Ja-Lok Ku 3, Roland Kontermann 4, Yong J Lee 1
J Oncol Res Ther. 2025;10(3):10302.
Link
3743. The Gaucher Earlier Diagnosis Consensus point-scoring system for children and young adults: a retrospective and prospective evaluation in Korea.
Hahn SM, Kim M, Kim Y, Oh J, Kim SH, Koh H, Kim SE, Chung NG, Shim YJ, Kim H, Lee JM, Yoon SS, Im HJ, Kang HJ, Do YR, Nam CM, Lyu CJ.
Orphanet J Rare Dis. 2025 Nov 20(1):569.
Link
3742. Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS study.
Baruchel A, Nysom K, Kang HJ, Felice MS, Michalowski MB, Freigeiro D, Epelman S, Lopes de Sousa AV, Valera ET, Moreira L, Leverger G, Nelken B, Kattamis A, Rizzari C, Fagioli F, Cesaro S, Gonzalez-Llano O, Buechner J, Choque WQ, Duarte J, Abrahamsson J, Alarcon A, Wang L, Mace S, Oprea C, Abbadessa G, Zwaan CM.
Hemasphere. 2025 Oct 9(10):e70245.
Link
3741. Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemi.
Yang H, Li V, Park SJ, Cheon SW, Lorant A, Mazumder A, Lee JY, Orlikova-Boyer B, Cerella C, Christov C, Kirsch G, Olberg DE, Bormans G, Kang HJ, Han BW, Schnekenburger M, Diederich M.
Clin Epigenetics. 2025 Jul 16;17(1):125.
Link
3740. Feasibility and safety of the synchroseal articulating bipolar energy-based device for robotic gastrectomy in patients with gastric cancer: a prospective single-arm clinical trial with historical controls
Ji-Hyeon Park, JeeSun Kim, Danbi Lee, Seong-Ho Kong, Do Joong Park, Hyuk-Joon Lee, Han-Kwang Yang
Updates Surg
. 2025 Dec;77(8):2255-2265
Link
3739. Textbook outcome of gastric cancer surgery and lymph node evaluation as its parameter to improve long-term survival
Cho YS, Kim S, Kim J, Kwak Y, Suh YS, Kong SH, Lee HS, Park DJ, Lee HJ, Kim WH, Yang HK.
Sci Rep. 2025 Oct 1;15(1):34159.
Link
3738. Lymph node metastasis prediction model for each lymph node station in gastric cancer patients
Kim JW, Hong H, Park SH, Choi JH, Suh YS, Kong SH, Park DJ, Lee HJ, Lee HS, Kwak Y, Kim WH, Sano T, Yang HK.
Eur J Surg Oncol. 2025 Aug;51(8):109590.
Link
3737. Long-term natural course of patients with lymph node station 6 metastasis after pylorus-preserving gastrectomy
Kim TH, Kim IH, Kang SJ, Song GJ, Jung MR, Han HS, Nam SY, Kong SH.
Gastric Cancer. 2025 Jul;28(4):673-683.
Link
3736. Cancer-associated fibroblast-derived fibulin-5 promotes epithelial-mesenchymal transition in diffuse-type gastric cancer via cAMP response element-binding protein pathway, showing poor prognosis
Choi J, Kwak Y, Park M, Jo JY, Kang JH, Myeong-Cherl K, Kim HR, Kim G, Kong SH, Park DJ, Lee HS, Lee HJ, Kim JM, Kim SG, Yang HK, Ryu JK, Cho SJ.
Exp Mol Med. 2025 May;57(5):1106-1119.
Link